Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/05/2003US20030104389 Synthesis of biologically active compounds in cells
06/05/2003US20030104388 By methylase selection and inverse PCR amplification of the adjacent DNA containing the endonuclease gene.
06/05/2003US20030104385 Enzymatic polypeptide for use in the diagnosis and treatment of psychological disorders
06/05/2003US20030104384 Trangenic cell library for monitoring phenotypic adjustments associated with gene transfer
06/05/2003US20030104379 HY2 family of bilin reductases
06/05/2003US20030104377 Tenascin-C nucleic acid ligands
06/05/2003US20030104375 Light-driven energy generation using proteorhodopsin
06/05/2003US20030104369 Method for generation of longer cDNA fragments from sage tags for gene identification
06/05/2003US20030104362 Cell-cycle regulatory proteins from human pathogens, and uses related thereto
06/05/2003US20030104355 Adapter-directed display systems
06/05/2003US20030104352 Methods for analyzing the insertion capabilities of modified group II introns
06/05/2003US20030104302 Construct and method for making it
06/05/2003US20030104064 Biodegradable, resistant to salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics
06/05/2003US20030104045 Novel therapeutic binding molecule complexes
06/05/2003US20030104009 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
06/05/2003US20030104001 Mycobacterial sulfation pathway proteins and methods of use thereof
06/05/2003US20030103997 Can be used to inhibit the infectivity, replication and cytopathic effects of a virus, such as a retrovirus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection
06/05/2003US20030103986 TACI-immunoglobulin fusion proteins
06/05/2003US20030103982 Therapeutic using a bispecific antibody
06/05/2003US20030103978 Antibodies and antigen binding domains used to prevent or treat conditions relating to loss of bone mass and bone disorders; nucleic acid encoding antibodies and antigen binding domains
06/05/2003US20030103977 Monoclonal antibodies binds to protective epitopes on serotype A, B, C and D strains of Cryptococcal; therapeutic treatment and prevent cryptococcal infection, such as cryptococcal meningitis, in immunosuppressed patients
06/05/2003US20030103974 Administering an antibodies or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss
06/05/2003US20030103970 Natural human antibody
06/05/2003US20030103969 Therapeutic treatment using an anti-CD14 antibody
06/05/2003US20030103963 Complementary determining regions capable binding to the same antigen as the monoclonal antibody 8H9; inhibit competitive binding; isolated scFv of monoclonal antibody 8H9, antigen, antitumor agents
06/05/2003US20030103958 Gene expression; for catalysis of phytate to inositol and inorganic phosphate; heat resistance; for production of animal feeds
06/05/2003US20030103957 Comprises adenosine-diphosphate transferase activity; drug delivery; for suppressing inhibition of neuronal axon growth
06/05/2003US20030103952 Anaerobe targeted enzyme-mediated prodrug therapy
06/05/2003US20030103949 Cell proliferation
06/05/2003US20030103946 Immunotherapeutic methods and molecules
06/05/2003US20030103943 Multiple site delivery of adenoviral vector for the induction of angiogenesis
06/05/2003US20030103942 Comprises recombinant adeno-associated virus vectors encoding TNF antagonist; antiinflammatory agents for connective tissues and joints
06/05/2003US20030103941 Administering an interluekin-10 expressing nucleic acid to wound site to promote expression of exogenous interleukin-10 polypeptide
06/05/2003US20030103939 For enhanced transduction of eukaryotic cells; gene expression
06/05/2003US20030103937 Comprises interleukins for enhancing engraphment of bone marrow during transplantation; for treating allergies and blood disorders
06/05/2003US20030103936 Method of ex-vivo expansion of hematopoeitic cells using interleukin-3 (IL-3) multiple mutation polypeptides
06/05/2003US20030102510 Molecular detection chip including mosfet , molecular detection device employing the chip, and molecular detection method using the device
06/05/2003CA2852277A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2469772A1 Methods for the identification of inhibitors of alpha-aminoadipate reductase and homocitrate synthase as antibiotics
06/05/2003CA2469135A1 Production of eukaryotic proteins and nucleic acid molecules in c. elegans
06/05/2003CA2468955A1 Sirna expression system and process for producing functional gene knockdown cell or the like using the same
06/05/2003CA2468874A1 Method to isolate genes involved in aging
06/05/2003CA2468838A1 Methods of using improved polymerases
06/05/2003CA2468832A1 Method for producing a recombinant polypeptide
06/05/2003CA2468548A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
06/05/2003CA2468511A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468501A1 T-cell epitodes in carboxypeptidase g2
06/05/2003CA2468424A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468411A1 Method for detecting hybridization events in nucleic acids
06/05/2003CA2468409A1 Method for analyzing translation-controlled gene expression
06/05/2003CA2468408A1 Human cdnas and proteins and uses thereof
06/05/2003CA2468353A1 A novel homeobox gene
06/05/2003CA2468344A1 Methods and compositions for treating lesions of the respiratory epithelium
06/05/2003CA2468326A1 Protein-protein interactions in human immunodeficiency virus
06/05/2003CA2468316A1 Novel compositions and methods for cancer
06/05/2003CA2468312A1 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness
06/05/2003CA2468292A1 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
06/05/2003CA2468246A1 Increasing electro-gene transfer of nucleic acid molecules into host tissue
06/05/2003CA2468245A1 Magneto-optical bio-discs and systems including related methods
06/05/2003CA2468240A1 Muscle transcription factors
06/05/2003CA2468230A1 Glycopeptide remodeling using amidases
06/05/2003CA2468187A1 Peptides with growth inhibitory action
06/05/2003CA2468131A1 Disruption of the prostaglandin e synthase 2 gene
06/05/2003CA2468020A1 Osteopontin-related compositions and methods
06/05/2003CA2468016A1 Humanized collagen antibodies and related methods
06/05/2003CA2467858A1 Dna construct for assessing thymic function activity and therapeutical uses thereof
06/05/2003CA2467677A1 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
06/05/2003CA2467397A1 Flavivirus vaccine delivery system
06/05/2003CA2467202A1 Expression of polypeptides in rod outer segment membranes
06/05/2003CA2466881A1 Cell culture process
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2466627A1 Chromatographic purification of recombinant human erythropoietin
06/05/2003CA2466615A1 Detection and identification of enteric bacteria
06/05/2003CA2466431A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2466298A1 Methods of increasing protein expression levels
06/05/2003CA2465072A1 Treatment of micro-organism infection
06/05/2003CA2464839A1 Artificial genes for use as controls in gene expression analysis systems
06/05/2003CA2454397A1 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the cns
06/05/2003CA2435758A1 Polynucleotide therapy_against autoantigens for treating insulin dependent diabetes mellitus
06/04/2003EP1316618A2 Nucleic acids for marking objects
06/04/2003EP1316616A1 Method for producing linear DNA fragments for the in vitro expression of proteins
06/04/2003EP1316612A1 Isozymes of lacrimator component synthase and gene encoding the same
06/04/2003EP1316611A1 L-methionine gamma-lyase with modified function
06/04/2003EP1316610A1 Preparation comprising an enzyme for asymmetrical hydrolysis of N-substituted C3-C4 cyclic imino-2-carboxylic acid ester and method of using the same
06/04/2003EP1316609A1 Acetoacetyl-CoA thiolase and its use for identifying new fungicidal substances
06/04/2003EP1316608A1 Novel polypeptide
06/04/2003EP1316607A1 Pseudo-cyclic oligonucleobases for inhibiting tumor growth
06/04/2003EP1316606A1 Method for separation and purification of nucleic acid and unit for separation and purification of nucleic acid
06/04/2003EP1316605A2 Method for producing DNA
06/04/2003EP1316604A1 Novel thymidylate synthase mutants
06/04/2003EP1316599A1 Magnetic particles and process for producing the same
06/04/2003EP1316594A1 Silane group containing polymers
06/04/2003EP1316561A1 Fusion protein having enhanced in vivo erythropoietin activity
06/04/2003EP1316560A1 Novel human cancer/testis antigen and gene thereof
06/04/2003EP1316319A1 A novel gene therapy agent for haemophilia b and its preparation method
06/04/2003EP1316252A1 Disease-resistant plants and method of constructing the same
06/04/2003EP1316023A2 Specific identifiers of amino-acid and base sequences
06/04/2003EP1315970A1 Nucleic acid sequences and proteins involved in cellular senescence
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315963A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
1 ... 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 ... 4023